Interviews, Smart Manufacturing

Continuous Manufacturing of small molecule pharmaceuticals

Bayan Takizawa, Co-Founder & Chief Business Officer of CONTINUUS Pharmaceuticals, revealed his views on integrated Continuous Manufacturing of small molecule pharmaceuticals. CONTINUUS Pharmaceuticals developed the new technology platform for manufacturing of small molecules called Integrated Continuous Manufacturing (ICM). The continuous approach enables to reduce processes that take 200 days in batch to about 2 days. He also addresses risks and benefits of using data from MES to improve production in the pharmaceutical industry.

Leave a Reply

Your email address will not be published. Required fields are marked *